BioSpace News Archive

Align Technology, Inc. a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, reinforced its commitment to dental professionals by confirming its planned presence at the International Dental Show 2021 in Cologne, Germany on September 22-25, 2021.

Copenhagen, DK and Boston, MA, 20 July 2021 - On June 29, 2021, Zealand Pharma A/S initiated a share repurchase program to acquire Danish common stock for incentive programs in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 and the Commission Delegated Regulation 2016/1052 of 8 March 2016.

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein dysregulation expertise, today announced that it will present preclinical data on two of its Alzheimer’s disease (AD) programs at the Alzheimer’s Association International Conference® 2021 (AAIC®),

BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), today announced that it has granted stock options to acquire a total of 1,367,606 common shares effective June 30, 2020 at a price of $0.38 per share to directors and officers of the Company and an investor relations consultant.

Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced that the Board of Directors has appointed Kate McKinley, who has served as the Company’s Chief Commercial Officer (CCO) since 2019, to Chief Executive Officer (CEO) of Elevar, effective immediately.

Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), today announced the closing of its initial public offering (the “Offering”) of 2,300,000 ordinary shares at a public offering price of $9.50 per share.

Tokyo Electron Device (TED) and Cerebras Systems, a company dedicated to accelerating Artificial Intelligence (AI) compute, today announced the opening of the TED AI Lab, featuring the industry-leading Cerebras Systems CS-1 AI accelerator.

Through a collaborative effort, spearheaded by professors, Dr. Vladimir Yarov-Yarovoy and Dr. Heike Wulff at UC Davis and supported in part by an NIH initiative, researchers have utilized a venom peptide originally isolated from the Peruvian green velvet tarantula (Thrixopelma pruriens) that blocks Nav1.7 voltage-gated ion channels, an ion channel important in pain signaling.

Lyniate, the most trusted connector of healthcare worldwide, today announced that Diagnostic Support Services (DS2), a premier provider of data integration services to laboratories, has selected Lyniate Corepoint to enable advanced interoperability.

Lumenis Ltd, the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, is pleased to report that 100% of the hospitals named to U.S. News and World Report’s exclusive Best Hospitals Honor Roll have chosen Lumenis surgical lasers in their approach to delivering outstanding patient care.